nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCC2—type 2 diabetes mellitus	0.165	0.474	CbGaD
Daunorubicin—CYP1A2—type 2 diabetes mellitus	0.11	0.316	CbGaD
Daunorubicin—CYP3A4—type 2 diabetes mellitus	0.0731	0.21	CbGaD
Daunorubicin—ABCB11—Glyburide—type 2 diabetes mellitus	0.0409	0.115	CbGbCtD
Daunorubicin—ABCC1—Glyburide—type 2 diabetes mellitus	0.0291	0.0814	CbGbCtD
Daunorubicin—ABCC2—Glyburide—type 2 diabetes mellitus	0.0215	0.0602	CbGbCtD
Daunorubicin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0213	0.0595	CbGbCtD
Daunorubicin—ABCG2—Glyburide—type 2 diabetes mellitus	0.0194	0.0545	CbGbCtD
Daunorubicin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0189	0.0531	CbGbCtD
Daunorubicin—SLC22A2—Metformin—type 2 diabetes mellitus	0.016	0.0447	CbGbCtD
Daunorubicin—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0159	0.0447	CbGbCtD
Daunorubicin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0145	0.0405	CbGbCtD
Daunorubicin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0137	0.0384	CbGbCtD
Daunorubicin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0127	0.0357	CbGbCtD
Daunorubicin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0114	0.0319	CbGbCtD
Daunorubicin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0113	0.0318	CbGbCtD
Daunorubicin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0108	0.0301	CbGbCtD
Daunorubicin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0104	0.0291	CbGbCtD
Daunorubicin—CYP3A5—Losartan—type 2 diabetes mellitus	0.00985	0.0276	CbGbCtD
Daunorubicin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00941	0.0264	CbGbCtD
Daunorubicin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00907	0.0254	CbGbCtD
Daunorubicin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00821	0.023	CbGbCtD
Daunorubicin—CYP1A2—Losartan—type 2 diabetes mellitus	0.00733	0.0205	CbGbCtD
Daunorubicin—ABCB1—Glyburide—type 2 diabetes mellitus	0.00701	0.0196	CbGbCtD
Daunorubicin—ABCB1—Losartan—type 2 diabetes mellitus	0.00641	0.018	CbGbCtD
Daunorubicin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00622	0.0174	CbGbCtD
Daunorubicin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00596	0.0167	CbGbCtD
Daunorubicin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00596	0.0167	CbGbCtD
Daunorubicin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00564	0.0158	CbGbCtD
Daunorubicin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0042	0.0118	CbGbCtD
Daunorubicin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00384	0.0108	CbGbCtD
Daunorubicin—NR5A1—pancreas—type 2 diabetes mellitus	0.00122	0.0322	CbGeAlD
Daunorubicin—YWHAG—islet of Langerhans—type 2 diabetes mellitus	0.00115	0.0302	CbGeAlD
Daunorubicin—Doxorubicin—NOS1—type 2 diabetes mellitus	0.00113	0.389	CrCbGaD
Daunorubicin—TOP2B—islet of Langerhans—type 2 diabetes mellitus	0.0011	0.0291	CbGeAlD
Daunorubicin—ABCC6—retina—type 2 diabetes mellitus	0.00104	0.0275	CbGeAlD
Daunorubicin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00101	0.724	CbGdCrCtD
Daunorubicin—YWHAG—retina—type 2 diabetes mellitus	0.00098	0.0259	CbGeAlD
Daunorubicin—TOP2B—retina—type 2 diabetes mellitus	0.000944	0.0249	CbGeAlD
Daunorubicin—TOP2B—nephron tubule—type 2 diabetes mellitus	0.000889	0.0235	CbGeAlD
Daunorubicin—ABCC6—cardiovascular system—type 2 diabetes mellitus	0.00088	0.0232	CbGeAlD
Daunorubicin—POR—islet of Langerhans—type 2 diabetes mellitus	0.000871	0.023	CbGeAlD
Daunorubicin—ABCC6—kidney—type 2 diabetes mellitus	0.000861	0.0227	CbGeAlD
Daunorubicin—YWHAG—cardiovascular system—type 2 diabetes mellitus	0.000829	0.0219	CbGeAlD
Daunorubicin—YWHAG—kidney—type 2 diabetes mellitus	0.000811	0.0214	CbGeAlD
Daunorubicin—YWHAG—pancreas—type 2 diabetes mellitus	0.000806	0.0213	CbGeAlD
Daunorubicin—TOP2B—cardiovascular system—type 2 diabetes mellitus	0.000799	0.0211	CbGeAlD
Daunorubicin—XDH—kidney—type 2 diabetes mellitus	0.000791	0.0209	CbGeAlD
Daunorubicin—YWHAG—cortex of kidney—type 2 diabetes mellitus	0.00079	0.0208	CbGeAlD
Daunorubicin—TOP2B—kidney—type 2 diabetes mellitus	0.000781	0.0206	CbGeAlD
Daunorubicin—TOP2B—pancreas—type 2 diabetes mellitus	0.000776	0.0205	CbGeAlD
Daunorubicin—ABCC6—adipose tissue—type 2 diabetes mellitus	0.000776	0.0205	CbGeAlD
Daunorubicin—TOP2B—cortex of kidney—type 2 diabetes mellitus	0.000761	0.0201	CbGeAlD
Daunorubicin—YWHAG—adipose tissue—type 2 diabetes mellitus	0.000731	0.0193	CbGeAlD
Daunorubicin—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000705	0.0186	CbGeAlD
Daunorubicin—TOP2B—adipose tissue—type 2 diabetes mellitus	0.000704	0.0186	CbGeAlD
Daunorubicin—POR—nephron tubule—type 2 diabetes mellitus	0.000702	0.0185	CbGeAlD
Daunorubicin—SLC22A2—kidney—type 2 diabetes mellitus	0.00062	0.0164	CbGeAlD
Daunorubicin—Doxorubicin—NOS3—type 2 diabetes mellitus	0.000615	0.212	CrCbGaD
Daunorubicin—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000604	0.0159	CbGeAlD
Daunorubicin—POR—cortex of kidney—type 2 diabetes mellitus	0.0006	0.0158	CbGeAlD
Daunorubicin—Doxorubicin—NOS2—type 2 diabetes mellitus	0.000594	0.204	CrCbGaD
Daunorubicin—POR—adipose tissue—type 2 diabetes mellitus	0.000556	0.0147	CbGeAlD
Daunorubicin—ABCC6—liver—type 2 diabetes mellitus	0.000544	0.0144	CbGeAlD
Daunorubicin—TOP2A—adipose tissue—type 2 diabetes mellitus	0.000518	0.0137	CbGeAlD
Daunorubicin—YWHAG—liver—type 2 diabetes mellitus	0.000513	0.0135	CbGeAlD
Daunorubicin—XDH—liver—type 2 diabetes mellitus	0.0005	0.0132	CbGeAlD
Daunorubicin—TOP2B—liver—type 2 diabetes mellitus	0.000494	0.013	CbGeAlD
Daunorubicin—ABCC10—kidney—type 2 diabetes mellitus	0.000489	0.0129	CbGeAlD
Daunorubicin—ABCB11—liver—type 2 diabetes mellitus	0.000488	0.0129	CbGeAlD
Daunorubicin—ABCC10—cortex of kidney—type 2 diabetes mellitus	0.000476	0.0126	CbGeAlD
Daunorubicin—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000447	0.0118	CbGeAlD
Daunorubicin—ABCC10—adipose tissue—type 2 diabetes mellitus	0.000441	0.0116	CbGeAlD
Daunorubicin—CYP1B1—nephron tubule—type 2 diabetes mellitus	0.000438	0.0115	CbGeAlD
Daunorubicin—Doxorubicin—ABCC2—type 2 diabetes mellitus	0.000394	0.135	CrCbGaD
Daunorubicin—CYP1B1—cardiovascular system—type 2 diabetes mellitus	0.000393	0.0104	CbGeAlD
Daunorubicin—ABCC2—kidney—type 2 diabetes mellitus	0.000393	0.0104	CbGeAlD
Daunorubicin—POR—liver—type 2 diabetes mellitus	0.00039	0.0103	CbGeAlD
Daunorubicin—CYP1B1—kidney—type 2 diabetes mellitus	0.000385	0.0101	CbGeAlD
Daunorubicin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000384	0.276	CbGdCrCtD
Daunorubicin—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000383	0.0101	CbGeAlD
Daunorubicin—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000376	0.00991	CbGeAlD
Daunorubicin—CYP1B1—cortex of kidney—type 2 diabetes mellitus	0.000375	0.00989	CbGeAlD
Daunorubicin—CYP1B1—adipose tissue—type 2 diabetes mellitus	0.000347	0.00915	CbGeAlD
Daunorubicin—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000337	0.00889	CbGeAlD
Daunorubicin—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000326	0.0086	CbGeAlD
Daunorubicin—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000312	0.00823	CbGeAlD
Daunorubicin—ABCC10—liver—type 2 diabetes mellitus	0.000309	0.00816	CbGeAlD
Daunorubicin—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000303	0.00798	CbGeAlD
Daunorubicin—CYP1A1—kidney—type 2 diabetes mellitus	0.000272	0.00718	CbGeAlD
Daunorubicin—CYP3A5—kidney—type 2 diabetes mellitus	0.000266	0.00702	CbGeAlD
Daunorubicin—CYP3A5—pancreas—type 2 diabetes mellitus	0.000264	0.00697	CbGeAlD
Daunorubicin—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000259	0.00683	CbGeAlD
Daunorubicin—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000258	0.00681	CbGeAlD
Daunorubicin—ABCC2—liver—type 2 diabetes mellitus	0.000248	0.00655	CbGeAlD
Daunorubicin—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000245	0.00647	CbGeAlD
Daunorubicin—CYP1B1—liver—type 2 diabetes mellitus	0.000243	0.00642	CbGeAlD
Daunorubicin—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.00024	0.00632	CbGeAlD
Daunorubicin—ABCC1—liver—type 2 diabetes mellitus	0.000219	0.00577	CbGeAlD
Daunorubicin—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.0002	0.00527	CbGeAlD
Daunorubicin—CYP3A4—kidney—type 2 diabetes mellitus	0.0002	0.00527	CbGeAlD
Daunorubicin—ABCG2—liver—type 2 diabetes mellitus	0.000181	0.00478	CbGeAlD
Daunorubicin—CYP1A2—liver—type 2 diabetes mellitus	0.000174	0.0046	CbGeAlD
Daunorubicin—Doxorubicin—CYP3A4—type 2 diabetes mellitus	0.000174	0.0599	CrCbGaD
Daunorubicin—CYP1A1—liver—type 2 diabetes mellitus	0.000172	0.00454	CbGeAlD
Daunorubicin—ABCB1—retina—type 2 diabetes mellitus	0.000171	0.0045	CbGeAlD
Daunorubicin—CYP3A5—liver—type 2 diabetes mellitus	0.000168	0.00443	CbGeAlD
Daunorubicin—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000161	0.00424	CbGeAlD
Daunorubicin—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000144	0.00381	CbGeAlD
Daunorubicin—ABCB1—kidney—type 2 diabetes mellitus	0.000141	0.00373	CbGeAlD
Daunorubicin—ABCB1—pancreas—type 2 diabetes mellitus	0.00014	0.0037	CbGeAlD
Daunorubicin—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000138	0.00363	CbGeAlD
Daunorubicin—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000127	0.00336	CbGeAlD
Daunorubicin—CYP3A4—liver—type 2 diabetes mellitus	0.000126	0.00333	CbGeAlD
Daunorubicin—Discomfort—Metformin—type 2 diabetes mellitus	9.81e-05	0.000666	CcSEcCtD
Daunorubicin—Fatigue—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.000666	CcSEcCtD
Daunorubicin—Nausea—Glipizide—type 2 diabetes mellitus	9.78e-05	0.000664	CcSEcCtD
Daunorubicin—Vomiting—Glimepiride—type 2 diabetes mellitus	9.77e-05	0.000663	CcSEcCtD
Daunorubicin—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.74e-05	0.000661	CcSEcCtD
Daunorubicin—Constipation—Gliclazide—type 2 diabetes mellitus	9.73e-05	0.00066	CcSEcCtD
Daunorubicin—Pain—Gliclazide—type 2 diabetes mellitus	9.73e-05	0.00066	CcSEcCtD
Daunorubicin—Tremor—Losartan—type 2 diabetes mellitus	9.71e-05	0.000659	CcSEcCtD
Daunorubicin—Rash—Glimepiride—type 2 diabetes mellitus	9.69e-05	0.000657	CcSEcCtD
Daunorubicin—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.68e-05	0.000657	CcSEcCtD
Daunorubicin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.000656	CcSEcCtD
Daunorubicin—Rash—Sitagliptin—type 2 diabetes mellitus	9.66e-05	0.000655	CcSEcCtD
Daunorubicin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.65e-05	0.000655	CcSEcCtD
Daunorubicin—Headache—Glimepiride—type 2 diabetes mellitus	9.63e-05	0.000653	CcSEcCtD
Daunorubicin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.61e-05	0.000652	CcSEcCtD
Daunorubicin—Cough—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.000652	CcSEcCtD
Daunorubicin—Headache—Sitagliptin—type 2 diabetes mellitus	9.6e-05	0.000651	CcSEcCtD
Daunorubicin—Anaemia—Losartan—type 2 diabetes mellitus	9.58e-05	0.00065	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.53e-05	0.000646	CcSEcCtD
Daunorubicin—Agitation—Losartan—type 2 diabetes mellitus	9.52e-05	0.000646	CcSEcCtD
Daunorubicin—Oedema—Metformin—type 2 diabetes mellitus	9.52e-05	0.000646	CcSEcCtD
Daunorubicin—Tinnitus—Ramipril—type 2 diabetes mellitus	9.52e-05	0.000646	CcSEcCtD
Daunorubicin—Hypertension—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000645	CcSEcCtD
Daunorubicin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.49e-05	0.000643	CcSEcCtD
Daunorubicin—Flushing—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000643	CcSEcCtD
Daunorubicin—Infection—Metformin—type 2 diabetes mellitus	9.46e-05	0.000642	CcSEcCtD
Daunorubicin—Insomnia—Valsartan—type 2 diabetes mellitus	9.46e-05	0.000642	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.41e-05	0.000639	CcSEcCtD
Daunorubicin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.38e-05	0.000636	CcSEcCtD
Daunorubicin—Chest pain—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000636	CcSEcCtD
Daunorubicin—Myalgia—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000636	CcSEcCtD
Daunorubicin—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000636	CcSEcCtD
Daunorubicin—Shock—Metformin—type 2 diabetes mellitus	9.37e-05	0.000635	CcSEcCtD
Daunorubicin—Insomnia—Orlistat—type 2 diabetes mellitus	9.35e-05	0.000634	CcSEcCtD
Daunorubicin—Malaise—Losartan—type 2 diabetes mellitus	9.34e-05	0.000634	CcSEcCtD
Daunorubicin—Anxiety—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.000634	CcSEcCtD
Daunorubicin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.34e-05	0.000633	CcSEcCtD
Daunorubicin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.32e-05	0.000632	CcSEcCtD
Daunorubicin—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.32e-05	0.000632	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.31e-05	0.000631	CcSEcCtD
Daunorubicin—Somnolence—Valsartan—type 2 diabetes mellitus	9.3e-05	0.000631	CcSEcCtD
Daunorubicin—Syncope—Losartan—type 2 diabetes mellitus	9.29e-05	0.00063	CcSEcCtD
Daunorubicin—Leukopenia—Losartan—type 2 diabetes mellitus	9.28e-05	0.000629	CcSEcCtD
Daunorubicin—Discomfort—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.000628	CcSEcCtD
Daunorubicin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.21e-05	0.000624	CcSEcCtD
Daunorubicin—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.17e-05	0.000622	CcSEcCtD
Daunorubicin—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000622	CcSEcCtD
Daunorubicin—Palpitations—Losartan—type 2 diabetes mellitus	9.16e-05	0.000621	CcSEcCtD
Daunorubicin—Nausea—Glimepiride—type 2 diabetes mellitus	9.13e-05	0.000619	CcSEcCtD
Daunorubicin—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.12e-05	0.000618	CcSEcCtD
Daunorubicin—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.11e-05	0.000618	CcSEcCtD
Daunorubicin—Nausea—Sitagliptin—type 2 diabetes mellitus	9.1e-05	0.000617	CcSEcCtD
Daunorubicin—Asthenia—Glyburide—type 2 diabetes mellitus	9.09e-05	0.000617	CcSEcCtD
Daunorubicin—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000617	CcSEcCtD
Daunorubicin—Anorexia—Metformin—type 2 diabetes mellitus	9.08e-05	0.000616	CcSEcCtD
Daunorubicin—Cough—Losartan—type 2 diabetes mellitus	9.04e-05	0.000613	CcSEcCtD
Daunorubicin—Urticaria—Gliclazide—type 2 diabetes mellitus	9.04e-05	0.000613	CcSEcCtD
Daunorubicin—Alopecia—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000612	CcSEcCtD
Daunorubicin—Fatigue—Valsartan—type 2 diabetes mellitus	9.02e-05	0.000612	CcSEcCtD
Daunorubicin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9e-05	0.00061	CcSEcCtD
Daunorubicin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9e-05	0.00061	CcSEcCtD
Daunorubicin—Oedema—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.00061	CcSEcCtD
Daunorubicin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.00061	CcSEcCtD
Daunorubicin—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.98e-05	0.000609	CcSEcCtD
Daunorubicin—Pruritus—Glyburide—type 2 diabetes mellitus	8.97e-05	0.000608	CcSEcCtD
Daunorubicin—Constipation—Valsartan—type 2 diabetes mellitus	8.94e-05	0.000607	CcSEcCtD
Daunorubicin—ABCB1—liver—type 2 diabetes mellitus	8.93e-05	0.00236	CbGeAlD
Daunorubicin—Infection—Irbesartan—type 2 diabetes mellitus	8.93e-05	0.000606	CcSEcCtD
Daunorubicin—Fatigue—Orlistat—type 2 diabetes mellitus	8.91e-05	0.000604	CcSEcCtD
Daunorubicin—Erythema—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000603	CcSEcCtD
Daunorubicin—Shock—Irbesartan—type 2 diabetes mellitus	8.84e-05	0.0006	CcSEcCtD
Daunorubicin—Pain—Orlistat—type 2 diabetes mellitus	8.84e-05	0.000599	CcSEcCtD
Daunorubicin—Myalgia—Losartan—type 2 diabetes mellitus	8.82e-05	0.000598	CcSEcCtD
Daunorubicin—Chest pain—Losartan—type 2 diabetes mellitus	8.82e-05	0.000598	CcSEcCtD
Daunorubicin—Arthralgia—Losartan—type 2 diabetes mellitus	8.82e-05	0.000598	CcSEcCtD
Daunorubicin—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.82e-05	0.000598	CcSEcCtD
Daunorubicin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.8e-05	0.000597	CcSEcCtD
Daunorubicin—Anxiety—Losartan—type 2 diabetes mellitus	8.79e-05	0.000596	CcSEcCtD
Daunorubicin—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000595	CcSEcCtD
Daunorubicin—Rash—Bromocriptine—type 2 diabetes mellitus	8.74e-05	0.000593	CcSEcCtD
Daunorubicin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.73e-05	0.000592	CcSEcCtD
Daunorubicin—Discomfort—Losartan—type 2 diabetes mellitus	8.72e-05	0.000591	CcSEcCtD
Daunorubicin—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.7e-05	0.00059	CcSEcCtD
Daunorubicin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.69e-05	0.000589	CcSEcCtD
Daunorubicin—Headache—Bromocriptine—type 2 diabetes mellitus	8.69e-05	0.000589	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.68e-05	0.000588	CcSEcCtD
Daunorubicin—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.67e-05	0.000588	CcSEcCtD
Daunorubicin—Dry mouth—Losartan—type 2 diabetes mellitus	8.63e-05	0.000585	CcSEcCtD
Daunorubicin—Anorexia—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.000581	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.55e-05	0.00058	CcSEcCtD
Daunorubicin—Confusional state—Losartan—type 2 diabetes mellitus	8.53e-05	0.000578	CcSEcCtD
Daunorubicin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.51e-05	0.000578	CcSEcCtD
Daunorubicin—Dyspnoea—Metformin—type 2 diabetes mellitus	8.49e-05	0.000576	CcSEcCtD
Daunorubicin—Somnolence—Metformin—type 2 diabetes mellitus	8.47e-05	0.000574	CcSEcCtD
Daunorubicin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.46e-05	0.000574	CcSEcCtD
Daunorubicin—Oedema—Losartan—type 2 diabetes mellitus	8.46e-05	0.000574	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.45e-05	0.000573	CcSEcCtD
Daunorubicin—Infection—Losartan—type 2 diabetes mellitus	8.4e-05	0.00057	CcSEcCtD
Daunorubicin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.000569	CcSEcCtD
Daunorubicin—Tremor—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000565	CcSEcCtD
Daunorubicin—Shock—Losartan—type 2 diabetes mellitus	8.32e-05	0.000564	CcSEcCtD
Daunorubicin—Urticaria—Valsartan—type 2 diabetes mellitus	8.31e-05	0.000563	CcSEcCtD
Daunorubicin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.28e-05	0.000562	CcSEcCtD
Daunorubicin—Decreased appetite—Metformin—type 2 diabetes mellitus	8.28e-05	0.000561	CcSEcCtD
Daunorubicin—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.27e-05	0.000561	CcSEcCtD
Daunorubicin—Tachycardia—Losartan—type 2 diabetes mellitus	8.25e-05	0.00056	CcSEcCtD
Daunorubicin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000559	CcSEcCtD
Daunorubicin—Nausea—Bromocriptine—type 2 diabetes mellitus	8.24e-05	0.000559	CcSEcCtD
Daunorubicin—Fatigue—Metformin—type 2 diabetes mellitus	8.21e-05	0.000557	CcSEcCtD
Daunorubicin—Urticaria—Orlistat—type 2 diabetes mellitus	8.21e-05	0.000557	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.19e-05	0.000555	CcSEcCtD
Daunorubicin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.18e-05	0.000555	CcSEcCtD
Daunorubicin—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.17e-05	0.000554	CcSEcCtD
Daunorubicin—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.17e-05	0.000554	CcSEcCtD
Daunorubicin—Asthenia—Gliclazide—type 2 diabetes mellitus	8.17e-05	0.000554	CcSEcCtD
Daunorubicin—Agitation—Ramipril—type 2 diabetes mellitus	8.17e-05	0.000554	CcSEcCtD
Daunorubicin—Constipation—Metformin—type 2 diabetes mellitus	8.14e-05	0.000552	CcSEcCtD
Daunorubicin—Anorexia—Losartan—type 2 diabetes mellitus	8.06e-05	0.000547	CcSEcCtD
Daunorubicin—Vomiting—Glyburide—type 2 diabetes mellitus	8.06e-05	0.000547	CcSEcCtD
Daunorubicin—Pruritus—Gliclazide—type 2 diabetes mellitus	8.05e-05	0.000546	CcSEcCtD
Daunorubicin—Malaise—Ramipril—type 2 diabetes mellitus	8.01e-05	0.000544	CcSEcCtD
Daunorubicin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.01e-05	0.000543	CcSEcCtD
Daunorubicin—Rash—Glyburide—type 2 diabetes mellitus	7.99e-05	0.000542	CcSEcCtD
Daunorubicin—Somnolence—Irbesartan—type 2 diabetes mellitus	7.99e-05	0.000542	CcSEcCtD
Daunorubicin—Dermatitis—Glyburide—type 2 diabetes mellitus	7.98e-05	0.000542	CcSEcCtD
Daunorubicin—Syncope—Ramipril—type 2 diabetes mellitus	7.97e-05	0.00054	CcSEcCtD
Daunorubicin—Leukopenia—Ramipril—type 2 diabetes mellitus	7.95e-05	0.000539	CcSEcCtD
Daunorubicin—Headache—Glyburide—type 2 diabetes mellitus	7.94e-05	0.000539	CcSEcCtD
Daunorubicin—Palpitations—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000533	CcSEcCtD
Daunorubicin—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.85e-05	0.000532	CcSEcCtD
Daunorubicin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.00053	CcSEcCtD
Daunorubicin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.81e-05	0.00053	CcSEcCtD
Daunorubicin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.79e-05	0.000528	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.79e-05	0.000528	CcSEcCtD
Daunorubicin—Cough—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000526	CcSEcCtD
Daunorubicin—Fatigue—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000526	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.71e-05	0.000523	CcSEcCtD
Daunorubicin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.7e-05	0.000523	CcSEcCtD
Daunorubicin—Convulsion—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000522	CcSEcCtD
Daunorubicin—Constipation—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000521	CcSEcCtD
Daunorubicin—Pain—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000521	CcSEcCtD
Daunorubicin—Insomnia—Losartan—type 2 diabetes mellitus	7.65e-05	0.000519	CcSEcCtD
Daunorubicin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.61e-05	0.000516	CcSEcCtD
Daunorubicin—Urticaria—Metformin—type 2 diabetes mellitus	7.57e-05	0.000513	CcSEcCtD
Daunorubicin—Chest pain—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000513	CcSEcCtD
Daunorubicin—Arthralgia—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000513	CcSEcCtD
Daunorubicin—Myalgia—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000513	CcSEcCtD
Daunorubicin—Dyspnoea—Losartan—type 2 diabetes mellitus	7.54e-05	0.000511	CcSEcCtD
Daunorubicin—Anxiety—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000511	CcSEcCtD
Daunorubicin—Nausea—Glyburide—type 2 diabetes mellitus	7.53e-05	0.000511	CcSEcCtD
Daunorubicin—Abdominal pain—Metformin—type 2 diabetes mellitus	7.53e-05	0.000511	CcSEcCtD
Daunorubicin—Dizziness—Gliclazide—type 2 diabetes mellitus	7.53e-05	0.000511	CcSEcCtD
Daunorubicin—Somnolence—Losartan—type 2 diabetes mellitus	7.52e-05	0.00051	CcSEcCtD
Daunorubicin—Asthenia—Valsartan—type 2 diabetes mellitus	7.5e-05	0.000509	CcSEcCtD
Daunorubicin—Discomfort—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000507	CcSEcCtD
Daunorubicin—Asthenia—Orlistat—type 2 diabetes mellitus	7.41e-05	0.000503	CcSEcCtD
Daunorubicin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.000502	CcSEcCtD
Daunorubicin—Pruritus—Valsartan—type 2 diabetes mellitus	7.4e-05	0.000502	CcSEcCtD
Daunorubicin—Dry mouth—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000502	CcSEcCtD
Daunorubicin—Decreased appetite—Losartan—type 2 diabetes mellitus	7.35e-05	0.000499	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.35e-05	0.000498	CcSEcCtD
Daunorubicin—Confusional state—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000496	CcSEcCtD
Daunorubicin—Pruritus—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000496	CcSEcCtD
Daunorubicin—Fatigue—Losartan—type 2 diabetes mellitus	7.29e-05	0.000495	CcSEcCtD
Daunorubicin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000492	CcSEcCtD
Daunorubicin—Oedema—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000492	CcSEcCtD
Daunorubicin—Vomiting—Gliclazide—type 2 diabetes mellitus	7.24e-05	0.000491	CcSEcCtD
Daunorubicin—Pain—Losartan—type 2 diabetes mellitus	7.23e-05	0.000491	CcSEcCtD
Daunorubicin—Constipation—Losartan—type 2 diabetes mellitus	7.23e-05	0.000491	CcSEcCtD
Daunorubicin—Rash—Gliclazide—type 2 diabetes mellitus	7.18e-05	0.000487	CcSEcCtD
Daunorubicin—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.17e-05	0.000486	CcSEcCtD
Daunorubicin—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.15e-05	0.000485	CcSEcCtD
Daunorubicin—Urticaria—Irbesartan—type 2 diabetes mellitus	7.14e-05	0.000484	CcSEcCtD
Daunorubicin—Shock—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000484	CcSEcCtD
Daunorubicin—Headache—Gliclazide—type 2 diabetes mellitus	7.13e-05	0.000484	CcSEcCtD
Daunorubicin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.1e-05	0.000482	CcSEcCtD
Daunorubicin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.1e-05	0.000482	CcSEcCtD
Daunorubicin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000482	CcSEcCtD
Daunorubicin—Tachycardia—Ramipril—type 2 diabetes mellitus	7.08e-05	0.00048	CcSEcCtD
Daunorubicin—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.07e-05	0.00048	CcSEcCtD
Daunorubicin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.01e-05	0.000476	CcSEcCtD
Daunorubicin—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.97e-05	0.000473	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.92e-05	0.000469	CcSEcCtD
Daunorubicin—Dizziness—Valsartan—type 2 diabetes mellitus	6.92e-05	0.000469	CcSEcCtD
Daunorubicin—Anorexia—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000469	CcSEcCtD
Daunorubicin—Dizziness—Orlistat—type 2 diabetes mellitus	6.83e-05	0.000463	CcSEcCtD
Daunorubicin—Asthenia—Metformin—type 2 diabetes mellitus	6.83e-05	0.000463	CcSEcCtD
Daunorubicin—Nausea—Gliclazide—type 2 diabetes mellitus	6.76e-05	0.000459	CcSEcCtD
Daunorubicin—Pruritus—Metformin—type 2 diabetes mellitus	6.74e-05	0.000457	CcSEcCtD
Daunorubicin—Urticaria—Losartan—type 2 diabetes mellitus	6.72e-05	0.000456	CcSEcCtD
Daunorubicin—Body temperature increased—Losartan—type 2 diabetes mellitus	6.69e-05	0.000453	CcSEcCtD
Daunorubicin—Abdominal pain—Losartan—type 2 diabetes mellitus	6.69e-05	0.000453	CcSEcCtD
Daunorubicin—Vomiting—Valsartan—type 2 diabetes mellitus	6.65e-05	0.000451	CcSEcCtD
Daunorubicin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.000449	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000448	CcSEcCtD
Daunorubicin—Rash—Valsartan—type 2 diabetes mellitus	6.59e-05	0.000447	CcSEcCtD
Daunorubicin—Dermatitis—Valsartan—type 2 diabetes mellitus	6.59e-05	0.000447	CcSEcCtD
Daunorubicin—Vomiting—Orlistat—type 2 diabetes mellitus	6.57e-05	0.000446	CcSEcCtD
Daunorubicin—Insomnia—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000445	CcSEcCtD
Daunorubicin—Headache—Valsartan—type 2 diabetes mellitus	6.55e-05	0.000444	CcSEcCtD
Daunorubicin—Diarrhoea—Metformin—type 2 diabetes mellitus	6.52e-05	0.000442	CcSEcCtD
Daunorubicin—Rash—Orlistat—type 2 diabetes mellitus	6.52e-05	0.000442	CcSEcCtD
Daunorubicin—Dermatitis—Orlistat—type 2 diabetes mellitus	6.51e-05	0.000442	CcSEcCtD
Daunorubicin—Headache—Orlistat—type 2 diabetes mellitus	6.47e-05	0.000439	CcSEcCtD
Daunorubicin—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000439	CcSEcCtD
Daunorubicin—Asthenia—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000437	CcSEcCtD
Daunorubicin—Somnolence—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000437	CcSEcCtD
Daunorubicin—Pruritus—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000431	CcSEcCtD
Daunorubicin—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000428	CcSEcCtD
Daunorubicin—Dizziness—Metformin—type 2 diabetes mellitus	6.3e-05	0.000427	CcSEcCtD
Daunorubicin—Fatigue—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000424	CcSEcCtD
Daunorubicin—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.23e-05	0.000423	CcSEcCtD
Daunorubicin—Nausea—Valsartan—type 2 diabetes mellitus	6.21e-05	0.000421	CcSEcCtD
Daunorubicin—Constipation—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000421	CcSEcCtD
Daunorubicin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000417	CcSEcCtD
Daunorubicin—Nausea—Orlistat—type 2 diabetes mellitus	6.14e-05	0.000416	CcSEcCtD
Daunorubicin—Asthenia—Losartan—type 2 diabetes mellitus	6.07e-05	0.000412	CcSEcCtD
Daunorubicin—Vomiting—Metformin—type 2 diabetes mellitus	6.05e-05	0.000411	CcSEcCtD
Daunorubicin—Rash—Metformin—type 2 diabetes mellitus	6e-05	0.000407	CcSEcCtD
Daunorubicin—Dermatitis—Metformin—type 2 diabetes mellitus	6e-05	0.000407	CcSEcCtD
Daunorubicin—Pruritus—Losartan—type 2 diabetes mellitus	5.98e-05	0.000406	CcSEcCtD
Daunorubicin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000405	CcSEcCtD
Daunorubicin—Headache—Metformin—type 2 diabetes mellitus	5.97e-05	0.000405	CcSEcCtD
Daunorubicin—Dizziness—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000403	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000402	CcSEcCtD
Daunorubicin—Diarrhoea—Losartan—type 2 diabetes mellitus	5.79e-05	0.000392	CcSEcCtD
Daunorubicin—Urticaria—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000391	CcSEcCtD
Daunorubicin—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000389	CcSEcCtD
Daunorubicin—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000389	CcSEcCtD
Daunorubicin—Vomiting—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000388	CcSEcCtD
Daunorubicin—Rash—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000384	CcSEcCtD
Daunorubicin—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.66e-05	0.000384	CcSEcCtD
Daunorubicin—Nausea—Metformin—type 2 diabetes mellitus	5.66e-05	0.000384	CcSEcCtD
Daunorubicin—Headache—Irbesartan—type 2 diabetes mellitus	5.63e-05	0.000382	CcSEcCtD
Daunorubicin—Dizziness—Losartan—type 2 diabetes mellitus	5.59e-05	0.000379	CcSEcCtD
Daunorubicin—Vomiting—Losartan—type 2 diabetes mellitus	5.38e-05	0.000365	CcSEcCtD
Daunorubicin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000362	CcSEcCtD
Daunorubicin—Nausea—Irbesartan—type 2 diabetes mellitus	5.34e-05	0.000362	CcSEcCtD
Daunorubicin—Rash—Losartan—type 2 diabetes mellitus	5.33e-05	0.000362	CcSEcCtD
Daunorubicin—Dermatitis—Losartan—type 2 diabetes mellitus	5.33e-05	0.000361	CcSEcCtD
Daunorubicin—Headache—Losartan—type 2 diabetes mellitus	5.3e-05	0.000359	CcSEcCtD
Daunorubicin—Asthenia—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000353	CcSEcCtD
Daunorubicin—Pruritus—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000348	CcSEcCtD
Daunorubicin—Nausea—Losartan—type 2 diabetes mellitus	5.02e-05	0.000341	CcSEcCtD
Daunorubicin—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000337	CcSEcCtD
Daunorubicin—Dizziness—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000325	CcSEcCtD
Daunorubicin—Vomiting—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000313	CcSEcCtD
Daunorubicin—Rash—Ramipril—type 2 diabetes mellitus	4.57e-05	0.00031	CcSEcCtD
Daunorubicin—Dermatitis—Ramipril—type 2 diabetes mellitus	4.57e-05	0.00031	CcSEcCtD
Daunorubicin—Headache—Ramipril—type 2 diabetes mellitus	4.54e-05	0.000308	CcSEcCtD
Daunorubicin—Nausea—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000292	CcSEcCtD
Daunorubicin—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.52e-06	3.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.51e-06	3.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	3.51e-06	3.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.49e-06	3.34e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	3.49e-06	3.34e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	3.48e-06	3.33e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	3.48e-06	3.33e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOS3—type 2 diabetes mellitus	3.47e-06	3.32e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	3.47e-06	3.32e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	3.45e-06	3.3e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	3.43e-06	3.28e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.42e-06	3.27e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	3.41e-06	3.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.41e-06	3.26e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.41e-06	3.26e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	3.39e-06	3.25e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	3.38e-06	3.24e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	3.38e-06	3.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.38e-06	3.23e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	3.38e-06	3.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3.35e-06	3.21e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	3.34e-06	3.2e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—INS—type 2 diabetes mellitus	3.32e-06	3.17e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.31e-06	3.17e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	3.29e-06	3.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	3.29e-06	3.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	3.29e-06	3.15e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.27e-06	3.13e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARG—type 2 diabetes mellitus	3.27e-06	3.13e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	3.24e-06	3.1e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	3.24e-06	3.1e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	3.24e-06	3.1e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	3.23e-06	3.1e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—INS—type 2 diabetes mellitus	3.21e-06	3.07e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	3.21e-06	3.07e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.21e-06	3.07e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	3.19e-06	3.06e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	3.18e-06	3.04e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	3.18e-06	3.04e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	3.15e-06	3.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	3.15e-06	3.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.1e-06	2.96e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.09e-06	2.96e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.08e-06	2.95e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	3.06e-06	2.93e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	3.04e-06	2.91e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	3.03e-06	2.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.03e-06	2.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.02e-06	2.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	3.02e-06	2.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	2.98e-06	2.85e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	2.97e-06	2.85e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	2.97e-06	2.85e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.96e-06	2.84e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	2.96e-06	2.83e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	2.96e-06	2.83e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	2.94e-06	2.82e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALB—type 2 diabetes mellitus	2.94e-06	2.81e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.93e-06	2.8e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.93e-06	2.8e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	2.92e-06	2.79e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—INS—type 2 diabetes mellitus	2.92e-06	2.79e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	2.91e-06	2.78e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.91e-06	2.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	2.9e-06	2.78e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.9e-06	2.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	2.89e-06	2.77e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	2.89e-06	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.88e-06	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	2.88e-06	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	2.88e-06	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	2.88e-06	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	2.86e-06	2.74e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	2.86e-06	2.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.86e-06	2.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	2.85e-06	2.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	2.81e-06	2.69e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NOS3—type 2 diabetes mellitus	2.81e-06	2.69e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.81e-06	2.69e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.81e-06	2.69e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2.81e-06	2.69e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.81e-06	2.69e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.8e-06	2.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.8e-06	2.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.8e-06	2.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.8e-06	2.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	2.78e-06	2.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	2.77e-06	2.66e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	2.76e-06	2.64e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	2.74e-06	2.62e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.7e-06	2.59e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	2.69e-06	2.58e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.68e-06	2.57e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	2.67e-06	2.56e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	2.66e-06	2.55e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	2.65e-06	2.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	2.63e-06	2.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	2.62e-06	2.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.59e-06	2.48e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.59e-06	2.48e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.58e-06	2.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.58e-06	2.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.58e-06	2.47e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	2.58e-06	2.47e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—type 2 diabetes mellitus	2.57e-06	2.46e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SRC—type 2 diabetes mellitus	2.57e-06	2.46e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.56e-06	2.45e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	2.56e-06	2.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.54e-06	2.43e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.53e-06	2.42e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	2.53e-06	2.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.51e-06	2.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	2.5e-06	2.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.49e-06	2.39e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.48e-06	2.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.48e-06	2.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.46e-06	2.36e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-06	2.35e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.45e-06	2.34e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	2.44e-06	2.33e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.42e-06	2.32e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.42e-06	2.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.42e-06	2.32e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—type 2 diabetes mellitus	2.41e-06	2.31e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.41e-06	2.31e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.38e-06	2.28e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.36e-06	2.26e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	2.36e-06	2.26e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	2.34e-06	2.24e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.34e-06	2.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.33e-06	2.23e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	2.32e-06	2.22e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.32e-06	2.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	2.31e-06	2.21e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.31e-06	2.21e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	2.3e-06	2.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	2.29e-06	2.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.28e-06	2.18e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.28e-06	2.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.28e-06	2.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.27e-06	2.17e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—type 2 diabetes mellitus	2.25e-06	2.16e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.24e-06	2.15e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.24e-06	2.15e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.24e-06	2.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.24e-06	2.14e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.22e-06	2.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.22e-06	2.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.22e-06	2.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.21e-06	2.12e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.2e-06	2.11e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.17e-06	2.08e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.16e-06	2.06e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.15e-06	2.06e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.15e-06	2.05e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.13e-06	2.04e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.09e-06	2e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.09e-06	2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.07e-06	1.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	2.01e-06	1.93e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.99e-06	1.91e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.99e-06	1.91e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.99e-06	1.91e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.98e-06	1.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.97e-06	1.89e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.96e-06	1.87e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.95e-06	1.86e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.94e-06	1.86e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.93e-06	1.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.93e-06	1.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.92e-06	1.84e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.92e-06	1.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.9e-06	1.82e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.9e-06	1.82e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.88e-06	1.8e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.85e-06	1.77e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.85e-06	1.77e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.84e-06	1.76e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.83e-06	1.76e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.83e-06	1.76e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.83e-06	1.75e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.82e-06	1.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.81e-06	1.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.8e-06	1.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.8e-06	1.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.79e-06	1.72e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—type 2 diabetes mellitus	1.78e-06	1.7e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.76e-06	1.68e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.73e-06	1.66e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.73e-06	1.66e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—type 2 diabetes mellitus	1.73e-06	1.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.73e-06	1.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.73e-06	1.66e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.72e-06	1.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.72e-06	1.64e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-06	1.61e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.67e-06	1.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.65e-06	1.58e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.61e-06	1.54e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—type 2 diabetes mellitus	1.6e-06	1.53e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.58e-06	1.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.58e-06	1.52e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.58e-06	1.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.55e-06	1.49e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.5e-06	1.44e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.49e-06	1.43e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.49e-06	1.43e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.48e-06	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.48e-06	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.47e-06	1.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.46e-06	1.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.46e-06	1.4e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.45e-06	1.38e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.42e-06	1.36e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	1.32e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	1.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.38e-06	1.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.36e-06	1.3e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	1.28e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.33e-06	1.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.32e-06	1.27e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—type 2 diabetes mellitus	1.29e-06	1.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.29e-06	1.23e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.28e-06	1.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.27e-06	1.22e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.27e-06	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.26e-06	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.22e-06	1.17e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.2e-06	1.15e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	1.13e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.11e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.16e-06	1.11e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.15e-06	1.11e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.14e-06	1.09e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.14e-06	1.09e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.12e-06	1.08e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.1e-06	1.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.1e-06	1.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	9.67e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.91e-07	9.49e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.72e-07	9.3e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.91e-07	8.53e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.52e-07	8.16e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.52e-07	8.16e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	8.43e-07	8.07e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	7.96e-07	7.62e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.79e-07	7.46e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.36e-07	6.09e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.08e-07	4.86e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.92e-07	3.75e-06	CbGpPWpGaD
